Several of the events took place at ‘upscale restaurants’ in San Francisco, at costs of up to $163 per person, according to ...

Gilead’s daily antiviral pills can prevent HIV transmission and slow AIDS. While an HIV vaccine remains the Holy Grail, Gilead’s new long-lasting injection, lenacapavir, is the next best thing.

Gilead Sciences is laying off 36 people as part of a rethink that saw the Big Pharma scrap plans to expand a biologics facility in California. At one point, the company had been planning to expand ...

On some negative news about one of its investigational programs, the stock of pharmaceutical company Gilead Sciences (GILD 0.73%) took some hits on Tuesday.

Recently, Zacks.com users have been paying close attention to Gilead (GILD). This makes it worthwhile to examine what the stock has in store.

Gilead Sciences agreed to pay $202 million to the U.S. government and various states to settle civil claims that the drugmaker used speaker programs to pay kickbacks to doctors to induce them to ...

Gilead Sciences (GILD) shares fell Friday, a day after the biopharmaceutical firm reported weak sales of its COVID-19 and cancer treatments, and cut its full-year profit guidance.

The redesigned map of the New York City system, the first to be introduced in nearly half a century, is reminiscent of a version from the 1970s that was reviled by many traditionalists.

Stock of the Day: Gilead Sciences falls on report the Trump administration could slash funds for HIV prevention John Moore/Getty Images ...

Gilead's dominance in HIV faces Medicare pricing challenges, limiting growth.

Gilead Sciences is rated a Strong Buy due to strong Q4 2024 results and a robust HIV franchise. Check out my 12-month price target for GILD stock.